{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Physique nucléaire : Questions médicales les plus fréquentes",
"headline": "Physique nucléaire : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Physique nucléaire : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-01-24",
"dateModified": "2025-04-18",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Physique nucléaire"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Physique",
"url": "https://questionsmedicales.fr/mesh/D010825",
"about": {
"@type": "MedicalCondition",
"name": "Physique",
"code": {
"@type": "MedicalCode",
"code": "D010825",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "H01.671"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Théorie quantique",
"alternateName": "Quantum Theory",
"url": "https://questionsmedicales.fr/mesh/D011789",
"about": {
"@type": "MedicalCondition",
"name": "Théorie quantique",
"code": {
"@type": "MedicalCode",
"code": "D011789",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "H01.671.579.800"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Théorie de la fonctionnelle de la densité",
"alternateName": "Density Functional Theory",
"url": "https://questionsmedicales.fr/mesh/D000077318",
"about": {
"@type": "MedicalCondition",
"name": "Théorie de la fonctionnelle de la densité",
"code": {
"@type": "MedicalCode",
"code": "D000077318",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "H01.671.579.800.500"
}
}
}
]
}
],
"about": {
"@type": "MedicalCondition",
"name": "Physique nucléaire",
"alternateName": "Nuclear Physics",
"code": {
"@type": "MedicalCode",
"code": "D009686",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Bart W Hoogenboom",
"url": "https://questionsmedicales.fr/author/Bart%20W%20Hoogenboom",
"affiliation": {
"@type": "Organization",
"name": "Department of Physics and Astronomy; Institute for the Physics of Living Systems; London Centre for Nanotechnology, University College London, London, United Kingdom. Electronic address: b.hoogenboom@ucl.ac.uk."
}
},
{
"@type": "Person",
"name": "Anton Zilman",
"url": "https://questionsmedicales.fr/author/Anton%20Zilman",
"affiliation": {
"@type": "Organization",
"name": "Department of Physics, University of Toronto, Toronto, Ontario, Canada; Institute for Biomedical Engineering, Toronto, Ontario, Canada. Electronic address: zilmana@physics.utoronto.ca."
}
},
{
"@type": "Person",
"name": "Jan Lammerding",
"url": "https://questionsmedicales.fr/author/Jan%20Lammerding",
"affiliation": {
"@type": "Organization",
"name": "Meinig School of Biomedical Engineering, Cornell University, Ithaca, NY 14853, USA; Weill Institute for Cell and Molecular Biology, Cornell University, Ithaca, NY 14853, USA. Electronic address: jan.lammerding@cornell.edu."
}
},
{
"@type": "Person",
"name": "Pavel Hozák",
"url": "https://questionsmedicales.fr/author/Pavel%20Hoz%C3%A1k",
"affiliation": {
"@type": "Organization",
"name": "Department of Biology of the Cell Nucleus, Institute of Molecular Genetics of the Czech Academy of Sciences, v.v.i., 142 20, Prague, Czech Republic; Department of Epigenetics of the Cell Nucleus, Institute of Molecular Genetics of the Czech Academy of Sciences, v.v.i., division BIOCEV, 25250, Vestec, Czech Republic; Microscopy Centre, Institute of Molecular Genetics of the Czech Academy of Sciences, v.v.i., 142 20, Prague, Czech Republic. Electronic address: hozak@img.cas.cz."
}
},
{
"@type": "Person",
"name": "Symeon Siniossoglou",
"url": "https://questionsmedicales.fr/author/Symeon%20Siniossoglou",
"affiliation": {
"@type": "Organization",
"name": "Cambridge Institute for Medical Research, University of Cambridge, Cambridge CB2 0XY, UK."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Validation of the RSClin risk calculator in the National Cancer Data Base.",
"datePublished": "2023-12-26",
"url": "https://questionsmedicales.fr/article/38146744",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1002/cncr.35163"
}
},
{
"@type": "ScholarlyArticle",
"name": "Prediction of Photochromism of Salicylideneaniline Crystals Using a Data Mining Approach.",
"datePublished": "2023-12-22",
"url": "https://questionsmedicales.fr/article/38222500",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1021/acsomega.3c07859"
}
},
{
"@type": "ScholarlyArticle",
"name": "Predictors of treatment switching in the Big Multiple Sclerosis Data Network.",
"datePublished": "2023-12-22",
"url": "https://questionsmedicales.fr/article/38187157",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3389/fneur.2023.1274194"
}
},
{
"@type": "ScholarlyArticle",
"name": "Distorted correlations among censored data: causes, effects, and correction.",
"datePublished": "2023-12-21",
"url": "https://questionsmedicales.fr/article/38129736",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3758/s13428-023-02086-5"
}
},
{
"@type": "ScholarlyArticle",
"name": "Federated Fuzzy Clustering for Decentralized Incomplete Longitudinal Behavioral Data.",
"datePublished": "2023-12-18",
"url": "https://questionsmedicales.fr/article/38605934",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1109/jiot.2023.3343719"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Disciplines des sciences naturelles",
"item": "https://questionsmedicales.fr/mesh/D010811"
},
{
"@type": "ListItem",
"position": 3,
"name": "Physique",
"item": "https://questionsmedicales.fr/mesh/D010825"
},
{
"@type": "ListItem",
"position": 4,
"name": "Physique nucléaire",
"item": "https://questionsmedicales.fr/mesh/D009686"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Physique nucléaire - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Physique nucléaire",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-11",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Physique nucléaire",
"description": "Comment la physique nucléaire aide-t-elle au diagnostic médical ?\nQuels tests utilisent la physique nucléaire pour le cancer ?\nQu'est-ce que la radiographie ?\nQuels sont les marqueurs radioactifs ?\nComment la physique nucléaire aide-t-elle en cardiologie ?",
"url": "https://questionsmedicales.fr/mesh/D009686?mesh_terms=Data+Collection&page=997#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Physique nucléaire",
"description": "Quels symptômes peuvent indiquer une exposition aux radiations ?\nComment reconnaître une maladie liée aux radiations ?\nQuels signes d'alerte pour une intoxication radioactive ?\nQuels symptômes d'une surdose de radiothérapie ?\nQuels symptômes d'une maladie thyroïdienne causée par radiations ?",
"url": "https://questionsmedicales.fr/mesh/D009686?mesh_terms=Data+Collection&page=997#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Physique nucléaire",
"description": "Comment prévenir l'exposition aux radiations ?\nQuelles sont les recommandations pour les travailleurs exposés ?\nComment réduire les risques de cancer par radiothérapie ?\nQuelles mesures de sécurité en médecine nucléaire ?\nComment se préparer à une scintigraphie ?",
"url": "https://questionsmedicales.fr/mesh/D009686?mesh_terms=Data+Collection&page=997#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Physique nucléaire",
"description": "Quels traitements utilisent la physique nucléaire ?\nComment fonctionne la radiothérapie ?\nQu'est-ce que la thérapie par isotopes ?\nQuels sont les effets secondaires de la radiothérapie ?\nComment la médecine nucléaire traite-t-elle le cancer ?",
"url": "https://questionsmedicales.fr/mesh/D009686?mesh_terms=Data+Collection&page=997#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Physique nucléaire",
"description": "Quelles complications peuvent survenir après une radiothérapie ?\nQuels risques à long terme de la radiothérapie ?\nQuelles complications de la médecine nucléaire ?\nComment gérer les effets secondaires de la radiothérapie ?\nQuels sont les effets à long terme des radiations ?",
"url": "https://questionsmedicales.fr/mesh/D009686?mesh_terms=Data+Collection&page=997#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Physique nucléaire",
"description": "Quels sont les facteurs de risque de cancer lié aux radiations ?\nComment l'environnement influence-t-il le risque de radiations ?\nQuels comportements augmentent le risque de maladies liées aux radiations ?\nQuel rôle joue la génétique dans le risque de cancer ?\nComment l'âge affecte-t-il le risque de maladies liées aux radiations ?",
"url": "https://questionsmedicales.fr/mesh/D009686?mesh_terms=Data+Collection&page=997#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment la physique nucléaire aide-t-elle au diagnostic médical ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle permet l'utilisation d'imageries comme la TEP et la scintigraphie pour diagnostiquer des maladies."
}
},
{
"@type": "Question",
"name": "Quels tests utilisent la physique nucléaire pour le cancer ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "La scintigraphie et la TEP sont couramment utilisées pour détecter et évaluer le cancer."
}
},
{
"@type": "Question",
"name": "Qu'est-ce que la radiographie ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "C'est une technique d'imagerie utilisant des rayons X pour visualiser les structures internes du corps."
}
},
{
"@type": "Question",
"name": "Quels sont les marqueurs radioactifs ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ce sont des substances radioactives utilisées pour suivre des processus biologiques dans le corps."
}
},
{
"@type": "Question",
"name": "Comment la physique nucléaire aide-t-elle en cardiologie ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle permet des tests comme la scintigraphie myocardique pour évaluer la fonction cardiaque."
}
},
{
"@type": "Question",
"name": "Quels symptômes peuvent indiquer une exposition aux radiations ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Nausées, vomissements, fatigue, et brûlures cutanées peuvent survenir après exposition."
}
},
{
"@type": "Question",
"name": "Comment reconnaître une maladie liée aux radiations ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des symptômes comme des douleurs abdominales, des saignements et des infections fréquentes peuvent apparaître."
}
},
{
"@type": "Question",
"name": "Quels signes d'alerte pour une intoxication radioactive ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Fatigue extrême, perte de cheveux, et troubles neurologiques peuvent être des signes d'intoxication."
}
},
{
"@type": "Question",
"name": "Quels symptômes d'une surdose de radiothérapie ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Rougeurs cutanées, douleurs, et fatigue excessive peuvent indiquer une surdose."
}
},
{
"@type": "Question",
"name": "Quels symptômes d'une maladie thyroïdienne causée par radiations ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent des changements de poids, fatigue, et troubles de l'humeur."
}
},
{
"@type": "Question",
"name": "Comment prévenir l'exposition aux radiations ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Utiliser des équipements de protection, limiter le temps d'exposition et maintenir une distance sûre."
}
},
{
"@type": "Question",
"name": "Quelles sont les recommandations pour les travailleurs exposés ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils doivent suivre des protocoles de sécurité stricts et subir des contrôles réguliers de santé."
}
},
{
"@type": "Question",
"name": "Comment réduire les risques de cancer par radiothérapie ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Évaluer soigneusement les bénéfices et les risques avant de commencer le traitement."
}
},
{
"@type": "Question",
"name": "Quelles mesures de sécurité en médecine nucléaire ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Utiliser des dispositifs de protection, surveiller les doses et former le personnel adéquatement."
}
},
{
"@type": "Question",
"name": "Comment se préparer à une scintigraphie ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Suivre les instructions du médecin, éviter certains aliments et hydrater avant l'examen."
}
},
{
"@type": "Question",
"name": "Quels traitements utilisent la physique nucléaire ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "La radiothérapie et la médecine nucléaire sont des traitements courants pour le cancer."
}
},
{
"@type": "Question",
"name": "Comment fonctionne la radiothérapie ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle utilise des rayonnements pour détruire les cellules cancéreuses tout en épargnant les tissus sains."
}
},
{
"@type": "Question",
"name": "Qu'est-ce que la thérapie par isotopes ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "C'est un traitement utilisant des isotopes radioactifs pour cibler des cellules malades, comme dans l'hyperthyroïdie."
}
},
{
"@type": "Question",
"name": "Quels sont les effets secondaires de la radiothérapie ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les effets incluent fatigue, nausées, et irritations cutanées, selon la zone traitée."
}
},
{
"@type": "Question",
"name": "Comment la médecine nucléaire traite-t-elle le cancer ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle utilise des agents radioactifs pour cibler et détruire les cellules cancéreuses."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir après une radiothérapie ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications comme des infections, des saignements et des dommages aux tissus peuvent survenir."
}
},
{
"@type": "Question",
"name": "Quels risques à long terme de la radiothérapie ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le risque de développer un cancer secondaire et des problèmes cardiaques peut augmenter."
}
},
{
"@type": "Question",
"name": "Quelles complications de la médecine nucléaire ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des réactions allergiques aux agents radioactifs et des effets indésirables peuvent se produire."
}
},
{
"@type": "Question",
"name": "Comment gérer les effets secondaires de la radiothérapie ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des soins de soutien, une bonne hydratation et des médicaments peuvent aider à gérer les effets."
}
},
{
"@type": "Question",
"name": "Quels sont les effets à long terme des radiations ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des problèmes de fertilité, des maladies cardiovasculaires et des cancers peuvent survenir."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque de cancer lié aux radiations ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'exposition professionnelle, les antécédents familiaux et l'âge avancé augmentent le risque."
}
},
{
"@type": "Question",
"name": "Comment l'environnement influence-t-il le risque de radiations ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les zones à forte radioactivité naturelle ou industrielle augmentent le risque d'exposition."
}
},
{
"@type": "Question",
"name": "Quels comportements augmentent le risque de maladies liées aux radiations ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Fumer, consommer de l'alcool et négliger les contrôles médicaux réguliers peuvent augmenter le risque."
}
},
{
"@type": "Question",
"name": "Quel rôle joue la génétique dans le risque de cancer ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines mutations génétiques peuvent prédisposer les individus à un risque accru de cancer."
}
},
{
"@type": "Question",
"name": "Comment l'âge affecte-t-il le risque de maladies liées aux radiations ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les personnes âgées sont souvent plus sensibles aux effets des radiations en raison de la dégradation cellulaire."
}
}
]
}
]
}
Guidelines recommend the use of genomic assays such as OncotypeDx to aid in decisions regarding the use of chemotherapy for hormone receptor-positive, HER2-negative (HR+/HER2-) breast cancer. The RSCl...
This study included patients from the National Cancer Data Base (NCDB) who were diagnosed with stage I-III HR+/HER2- breast cancer from 2010 to 2020 and received adjuvant endocrine therapy with or wit...
A total of 285,441 patients were identified for inclusion from the NCDB, with an average age of 60 years and a median follow-up of 58 months. Chemotherapy was associated with improved overall survival...
RSClin may identify high-risk patients who benefit from treatment intensification more accurately than OncotypeDx, and further prospective study is needed....
Salicylideneanilines (SAs) are photochromic compounds that undergo enol-keto photoisomerization in the solid state. Research over the past 60 years has revealed empirically that SAs with steric and pl...
Treatment switching is a common challenge and opportunity in real-world clinical practice. Increasing diversity in disease-modifying treatments (DMTs) has generated interest in the identification of r...
The objective of this retrospective, observational study was to identify independent predictors of treatment switching in a population of relapsing-remitting MS (RRMS) patients in the Big Multiple Scl...
In this cohort study, we merged information on 269,822 treatment episodes in 110,326 patients from 1997 to 2018 from five clinical registries. Patients were included in the final pooled analysis set i...
Every one-point increase in the Expanded Disability Status Scale (EDSS) score at treatment start was associated with 1.08 times the rate of subsequent switching, adjusting for age, sex, and calendar y...
Switching between DMTs is associated with female sex, age, and disability at baseline and has increased in frequency considerably in recent years as more treatment options have become available. Consi...
Data censoring occurs when researchers do not know precise values of data points (e.g., age is 55+ or concentration ≤ .001). Censoring is frequent within psychology but typically unrecognized outside ...
The use of medical data for machine learning, including unsupervised methods such as clustering, is often restricted by privacy regulations such as the Health Insurance Portability and Accountability ...
To improve health outcomes and address mounting costs pressures, policy-makers have encouraged primary care commissioners in the British National Health Service (NHS) to increase the usage of data in ...
A realist evaluation was completed to create context-mechanism-outcome configurations (CMOs) relating to the contexts influencing the usage of data in primary care commissioning. Using a realist logic...
Thirty-five CMOs were formed, resulting in an overarching realist programme theory. Thirteen CMOs were identical and 3 were truncated versions of those formed in an existing realist synthesis on the s...
Commissioners are enthusiastic about using data as a source of information, a tool to stimulate improvements, and a warrant for decision-making. However, they also face considerable challenges when us...
Due to the overall low abundance of volatile compounds in exhaled breath, it is necessary to preconcentrate the sample prior to traditional thermal desorption gas chromatography mass spectrometry (TD-...
Alzheimer's disease (AD) is an irreversible and progressive neurodegenerative disease. Longitudinal structural magnetic resonance imaging (sMRI) data have been widely used for tracking AD pathogenesis...
Despite advances in allogeneic hematopoietic cell transplantation, acute graft-versus-host disease (aGVHD) remains its leading complication, yet with heterogeneous outcomes. Here, we analyzed aGVHD ph...